OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Atorvastatin Attenuates Diet-Induced Non-Alcoholic Steatohepatitis in APOE*3-Leiden Mice by Reducing Hepatic Inflammation
José A. Inia, Geurt Stokman, Elsbet J. Pieterman, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7818-7818
Open Access | Times Cited: 12
José A. Inia, Geurt Stokman, Elsbet J. Pieterman, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7818-7818
Open Access | Times Cited: 12
Showing 12 citing articles:
Pravastatin reduces all-cause mortality in elderly at risk of liver fibrosis: post-hoc analysis of the PROSPER trial
Vivian D. de Jong, Willy Theel, Manuel Castro Cabezas, et al.
JHEP Reports (2025), pp. 101337-101337
Open Access | Times Cited: 1
Vivian D. de Jong, Willy Theel, Manuel Castro Cabezas, et al.
JHEP Reports (2025), pp. 101337-101337
Open Access | Times Cited: 1
A Systematic Review of Statins for the Treatment of Nonalcoholic Steatohepatitis: Safety, Efficacy, and Mechanism of Action
Shiqin Zhang, Xiaoling Ren, Bingzheng Zhang, et al.
Molecules (2024) Vol. 29, Iss. 8, pp. 1859-1859
Open Access | Times Cited: 12
Shiqin Zhang, Xiaoling Ren, Bingzheng Zhang, et al.
Molecules (2024) Vol. 29, Iss. 8, pp. 1859-1859
Open Access | Times Cited: 12
Statins and non-alcoholic fatty liver disease: A concise review
Evelyn Nunes Goulart da Silva Pereira, Ricardo Franco, Raul D. Santos, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117805-117805
Open Access
Evelyn Nunes Goulart da Silva Pereira, Ricardo Franco, Raul D. Santos, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117805-117805
Open Access
Protective effects of statins on the incidence of NAFLD –related decompensated cirrhosis in T2DM
Szu‐Yuan Wu, Wan‐Ming Chen, Ming‐Feng Chiang, et al.
Liver International (2023) Vol. 43, Iss. 10, pp. 2232-2244
Closed Access | Times Cited: 11
Szu‐Yuan Wu, Wan‐Ming Chen, Ming‐Feng Chiang, et al.
Liver International (2023) Vol. 43, Iss. 10, pp. 2232-2244
Closed Access | Times Cited: 11
Hypogonadism and nonalcoholic fatty liver disease
Kasiani Papadimitriou, Athanasios Mousiolis, Gesthimani Mintziori, et al.
Endocrine (2024) Vol. 86, Iss. 1, pp. 28-47
Closed Access | Times Cited: 3
Kasiani Papadimitriou, Athanasios Mousiolis, Gesthimani Mintziori, et al.
Endocrine (2024) Vol. 86, Iss. 1, pp. 28-47
Closed Access | Times Cited: 3
Cholesterol crystals in the pathogenesis of atherosclerosis
Yvonne Baumer, Jason Irei, William A. Boisvert
Nature Reviews Cardiology (2024)
Closed Access | Times Cited: 2
Yvonne Baumer, Jason Irei, William A. Boisvert
Nature Reviews Cardiology (2024)
Closed Access | Times Cited: 2
Three rare nor-sesquiterpenoids with lipid-lowering activity from Belamcanda chinensis
Yunhua Qianshi, Lei Huang, Jun Jin, et al.
Organic & Biomolecular Chemistry (2023) Vol. 21, Iss. 48, pp. 9640-9646
Closed Access | Times Cited: 4
Yunhua Qianshi, Lei Huang, Jun Jin, et al.
Organic & Biomolecular Chemistry (2023) Vol. 21, Iss. 48, pp. 9640-9646
Closed Access | Times Cited: 4
Atorvastatin on Treatment of Nonalcoholic Fatty Liver Disease Patients
Zahra Eslami, Samaneh Sadat Aghili, Amir Ghaleh Ghafi
Chonnam Medical Journal (2024) Vol. 60, Iss. 1, pp. 13-13
Open Access | Times Cited: 1
Zahra Eslami, Samaneh Sadat Aghili, Amir Ghaleh Ghafi
Chonnam Medical Journal (2024) Vol. 60, Iss. 1, pp. 13-13
Open Access | Times Cited: 1
Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes
Merve Çebi, Yusuf Yılmaz
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Merve Çebi, Yusuf Yılmaz
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Attenuation of high-fat high-sucrose diet and CCl4-induced non-alcoholic steatohepatitis in rats by activating autophagy and SIGMAR1/GRP78/ITPR1 signaling using berberine-loaded albumin nanoparticles: in vivo prediction and in-silico molecular modeling
Samar R. Saleh, Fatema A. Younis, Sahar S. Abdelrahman, et al.
Journal of Pharmaceutical Investigation (2024)
Open Access | Times Cited: 1
Samar R. Saleh, Fatema A. Younis, Sahar S. Abdelrahman, et al.
Journal of Pharmaceutical Investigation (2024)
Open Access | Times Cited: 1
Statins in Chronic Liver Disease: Review of the Literature and Future Role
Nguyen C. Pham, Jihane N. Benhammou
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 191-208
Closed Access
Nguyen C. Pham, Jihane N. Benhammou
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 191-208
Closed Access
Genome‐Wide Profiling of H3K27ac Identifies TDO2 as a Pivotal Therapeutic Target in Metabolic Associated Steatohepatitis Liver Disease
Yaling Zhu, Limeng Shang, Yunshu Tang, et al.
Advanced Science (2024)
Open Access
Yaling Zhu, Limeng Shang, Yunshu Tang, et al.
Advanced Science (2024)
Open Access
